These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8229699)

  • 1. Multiple-dose pharmacokinetics of moxisylyte after oral administration to healthy volunteers.
    Costa P; Bressolle F; Jarroux E; Sarrazin B; Mosser J; Navratil H; Galtier M
    J Pharm Sci; 1993 Sep; 82(9):968-71. PubMed ID: 8229699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and oral administration.
    Costa P; Bressolle F; Bromet-Petit M; Mosser J; Sarrazin B
    J Pharm Sci; 1992 Dec; 81(12):1223-6. PubMed ID: 1491345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and intracavernous administration.
    Costa P; Bressolle F; Sarrazin B; Mosser J; Galtier M
    J Pharm Sci; 1993 Jul; 82(7):729-33. PubMed ID: 8103112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of moxisylyte in healthy volunteers after intracavernous injection of increasing doses.
    Bressolle F; Costa P; Rouzier-Panis R; Marquer C
    Eur J Clin Pharmacol; 1996; 49(5):411-5. PubMed ID: 8866639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxisylyte plasma kinetics in humans after intracavernous administration.
    Costa P; Bressolle F; Sarrazin B; Mosser J; Navratil H; Galtier M
    Biopharm Drug Dispos; 1992 Dec; 13(9):671-9. PubMed ID: 1467454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of moxisylyte in healthy volunteers after intravenous infusion and intracavernous administration with and without a penile tourniquet.
    Costa P; Bressolle F; Mottet N; Rouzier-Panis R; Navratil H; Marquer C
    Ther Drug Monit; 1996 Apr; 18(2):135-44. PubMed ID: 8721275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 14C-moxisylyte in hairless rat. Comparison between intravenous and oral route.
    Neau B; Roux J; Lambrey B; Courtiol C; Marty JP; Grislain L
    Arzneimittelforschung; 1995 Jan; 45(1):10-4. PubMed ID: 7893260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of the conjugate metabolites of moxisylyte in human plasma and urine.
    Marquer C; Bressolle F
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):389-96. PubMed ID: 9174276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat.
    Neau B; Roux J; Courtiol C; Lambrey B; Marty JP
    Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers.
    Bressolle F; Galtier M; Kinowski JM; Goncalves F; Edno L; Panis R; Gomeni R
    J Pharm Sci; 1994 Sep; 83(9):1236-40. PubMed ID: 7830237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence.
    Marquer C; Bressolle F
    Fundam Clin Pharmacol; 1998; 12(4):377-87. PubMed ID: 9711459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 14C-moxisylyte after percutaneous application in hairless rat.
    Neau B; Roux J; Marty JP
    Arzneimittelforschung; 1998 Jan; 48(1):34-8. PubMed ID: 9522028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute and chronic effect of moxisylyte hydrochloride on the retinal circulation in diabetes mellitus].
    Sugihara I; Ishibashi T; Furutani S; Kurimoto S
    Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1135-41. PubMed ID: 1836935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
    Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a prodrug thymoxamine: dose-dependence of the metabolite ratio in healthy subjects.
    Marquer C; Trouvin JH; Lacolle JY; Dupont C; Jacquot C
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):183-8. PubMed ID: 1839981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of thymoxamine. II. Studies with 14C-thymoxamine in man.
    Vollmer KO; Poisson A
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):71-6. PubMed ID: 3161739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related effect of moxisylyte on maximal urethral closing pressure in patients with spinal cord injuries.
    Costa P; Bressolle F; Sarrazin B; Mosser J; Sabatier R
    Clin Pharmacol Ther; 1993 Apr; 53(4):443-9. PubMed ID: 8477560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and biotransformation of the antiretroviral drug nevirapine in humans.
    Riska P; Lamson M; MacGregor T; Sabo J; Hattox S; Pav J; Keirns J
    Drug Metab Dispos; 1999 Aug; 27(8):895-901. PubMed ID: 10421616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers.
    Dixon R; Gillotin C; Gibbens M; Posner J; Peck RW
    Br J Clin Pharmacol; 1997 Mar; 43(3):273-81. PubMed ID: 9088582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.